Real-World Assessment of Weight Change in People with HIV-1 After Initiating Integrase Strand Transfer Inhibitors or Protease Inhibitors
**Background:** Studies have shown an increase in weight among people living with human immunodeficiency virus (PLWH) who have also initiated integrase strand transfer inhibitors (INSTI). However, limited data are available regarding comparison of these changes with other antiretroviral regimens. *...
Saved in:
Main Authors: | Yen-Wen Chen, Helene Hardy, Christopher D. Pericone, Wing Chow |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2020-07-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/jheor.2020.13457 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Assessment of Weight Change in African American Females and Hispanics with HIV-1 After Initiating Integrase Strand-Transfer Inhibitors or Protease Inhibitors
by: Yen-Wen Chen, et al.
Published: (2022-01-01) -
A multiplex method for rapidly identifying viral protease inhibitors
by: Seo Jung Hong, et al.
Published: (2025-01-01) -
Efficacy and safety of new protease inhibitor faldaprevir in treatment of hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-12-01) -
Bicyclic peptide-enhanced covalent inhibitor of SARS-CoV-2 3CL protease
by: Qian Wang, et al.
Published: (2024-10-01) -
Efficacy and safety of the Russian protease inhibitor narlaprevir at treatment-naive and earlier treated noncirrhotic patients with the 1st genotype chronic hepatitis C (PIONEER study)
by: M. V. Mayevskaya, et al.
Published: (2018-08-01)